BMJ Best Practice

参考文献

关键文献

Whipple JK, Quebbeman EJ, Lewis KS, et al. Difficulties in diagnosing narcotic overdoses in hospitalized patients. Ann Pharmacother. 1994 Apr;28(4):446-50.

Kerr D, Dietze P, Kelly AM. Intranasal naloxone for the treatment of suspected heroin overdose. Addiction. 2008 Mar;103(3):379-86.

Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec;104(12):2067-74.

Howland MAH. Antidotes in depth opioid antagonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicological emergencies. 8th ed. New York, NY: McGraw-Hill; 2006:614-7.

参考文章

1.  Centers for Disease Control and Prevention. Opioid overdose: understanding the epidemic. December 2018 [internet publication].

2.  Drug Abuse Warning Network. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. February 2013 [internet publication].

3.  Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27.

4.  Seth P, Scholl L, Rudd RA, et al. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-58.

5.  Centres for Disease Control and Prevention (CDC). Rising numbers of deaths involving fentanyl and fentanyl analogs, including carfentanil, and increased usage and mixing with non-opioids. HAN no. 413. July 2018 [internet publication].

6.  Binswanger IA, Stern MF, Deyo RA, et al. Release from prison - a high risk of death for former inmates. N Engl J Med. 2007 Jan 11;356(2):157-65.

7.  Anoro M, Ilundain E, Rodriguez R, et al. Factors related to experiencing respiratory failure in cases of opiate overdose for which care was provided in an open setting. Barcelona, Spain. Rev Esp Salud Publica. 2004;78:601-608.

8.  Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89-96.

9.  Substance Abuse and Mental Health Services Administration (SAMHSA). Opioid overdose prevention toolkit. June 2018 [internet publication].

10.  US Department of Health and Human Services. Naloxone: the opioid reversal drug that saves lives. How healthcare providers and patients can better utilize this life-saving drug. December 2018 [internet publication].

11.  Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016 Mar 18;65(1):1-49.

12.  Chang AK, Bijur PE, Esses D, et al. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA. 2017 Nov 7;318(17):1661-7.

13.  Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991 Mar;20(3):246-52.

14.  Hierholzer J, Cordes M, Tantow H, et al. Drug smuggling by ingested cocaine-filled packages: conventional x-ray and ultrasound. Abdom Imaging. 1995 Jul-Aug;20(4):333-8.

15.  McCarron MM, Wood JD. The cocaine 'body packer' syndrome. Diagnosis and treatment. JAMA. 1983 Sep 16;250(11):1417-20.

16.  Whipple JK, Quebbeman EJ, Lewis KS, et al. Difficulties in diagnosing narcotic overdoses in hospitalized patients. Ann Pharmacother. 1994 Apr;28(4):446-50.

17.  Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012 Jul 12;367(2):146-55.

18.  O'Driscoll BR, Howard LS, Earis J, et al; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72(suppl 1):ii1-ii90.

19.  Mills CA, Flacke JW, Flacke WE, et al. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can J Anaesth. 1990 Mar;37(2):238-44.

20.  Mills CA, Flacke JW, Miller JD, et al. Cardiovascular effects of fentanyl reversal by naloxone at varying arterial carbon dioxide tensions in dogs. Anesth Analg. 1988 Aug;67(8):730-6.

21.  Thadani PV. NIDA conference report on cardiopulmonary complications of "crack" cocaine use. Clinical manifestations and pathophysiology. Chest. 1996 Oct;110(4):1072-6.

22.  Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334-49.

23.  Kerr D, Dietze P, Kelly AM. Intranasal naloxone for the treatment of suspected heroin overdose. Addiction. 2008 Mar;103(3):379-86.

24.  Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec;104(12):2067-74.

25.  Lobmaier PP, Dalsbø TK, Clausen T. Nasal naloxone may reduce the risk of death from heroin overdose [in Norwegian; English summary]. Nor J Epidemiol. 2011;21:107-11.

26.  Sutter ME, Gerona RR, Davis MT, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017 Jan;24(1):106-13.

27.  Rogers JS, Rehrer SJ, Hoot NR. Acetylfentanyl: an emerging drug of abuse. J Emerg Med. 2016 Mar;50(3):433-6.

28.  van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology. 2006 Jul;105(1):51-7.

29.  Gal TJ. Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther. 1989 Jan;45(1):66-71.

30.  Wong S, Ordean A, Kahan M; Working Group on Problematic Substance Use in Pregnancy. Society of Obstetricians and Gynaecologists of Canada clinical practice guideline: substance use in pregnancy. April 2011 [internet publication].

31.  Howland MAH. Antidotes in depth opioid antagonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicological emergencies. 8th ed. New York, NY: McGraw-Hill; 2006:614-7.

使用此内容应接受我们的免责声明。